DNA Sequencing: Emerging Technologies and Applications
March 15, 2012
Wellesley, Mass. – According to a new technical market research report, DNA SEQUENCING: EMERGING TECHNOLOGIES AND APPLICATIONS (BIO045D) from BCC Research (www.bccresearch.com), the global market for sequencing products and services was valued at nearly $3 billion in 2011, and is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.
The sequencing products market can be broken down into three segments: instruments and consumables, services, and workflow products.
The segment made up of instruments and consumables accounted for nearly $1.6 billion in 2011 and is expected to increase at a CAGR of 7.3% to reach $2.2 billion in 2016.
The services segment accounted for $987.6 million in 2011 and is expected to increase at a CAGR of 29% to reach $3.5 billion in 2016.
Workflow products, worth nearly $410 million in 2011, should reach $883.6 million in 2016 at a CAGR of 16.6%.
Segments of the sequencing applications market that will provide substantial future growth opportunities for industry participants include consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.
Each human genome contains approximately 3 billion base pairs of sequence. This sequence varies slightly from one individual to the next, which together with environmental factors accounts for the differences seen in people.
The most common form of single-base change is single nucleotide polymorphisms, or SNPs, which occur when a single nucleotide differs between individuals or paired chromosomes, resulting in at least two alleles. SNPs can be considered common, that is, occurring in greater than 1% of the general population, or rare, occurring in less than 1% of the population.
This study will be of particular interest to life science research tools suppliers, as well as pharmaceutical, diagnostics, nanotechnology, bioinformatics, semiconductor, and biotechnology companies. It also will be valuable to companies seeking to benefit from genome sequencing projects, microarray companies seeking an entry into the sequencing market, informatics companies who wish to expand their market reach, and in vitro diagnostics companies who want to add sequencing platforms to their portfolios.
DNA Sequencing: Emerging Technologies and Applications( BIO045D )
Publish Date: Mar 2012
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum